0001179110-20-009930.txt : 20200924 0001179110-20-009930.hdr.sgml : 20200924 20200924162212 ACCESSION NUMBER: 0001179110-20-009930 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200922 FILED AS OF DATE: 20200924 DATE AS OF CHANGE: 20200924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boral Anthony L. CENTRAL INDEX KEY: 0001638468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 201195529 MAIL ADDRESS: STREET 1: BLUEPRINT MEDICINES CORP. STREET 2: 215 FIRST STREET, SUITE 340/350 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-09-22 0 0001597264 Blueprint Medicines Corp BPMC 0001638468 Boral Anthony L. C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Common Stock 2020-09-22 4 M 0 6864 15.01 A 25828 D Common Stock 2020-09-22 4 S 0 6864 82.33 D 18964 D Stock Option (Right to Buy) 15.01 2020-09-22 4 M 0 6864 0 D 2026-02-03 Common Stock 6864 17483 D Effected pursuant to a trading plan adopted on March 17, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This option was granted on February 3, 2016. This option is fully vested as of the date hereof. /s/ Christopher Frankenfield, Attorney-in-Fact 2020-09-24